Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Investors
  • Our company
  • AZ on the issues
  • Responsible business
  • Newsroom
    • Media resources
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
  • US web sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• Research news

The following shows headlines of all research-related news articles published within 12-months, starting from most recent.

• Pages
• Previous
• 1
• 2

• • Jul 30, 2009
  • AstraZeneca submits New Drug Applications for ZACTIMA™ in second-line advanced non-small cell lung cancer  
• • Jun 4, 2009
  • AstraZeneca and Abbott submit New Drug Application to the FDA for CERTRIAD™, an investigational treatment for mixed dyslipidemia  
• • May 30, 2009
  • Phase III study data with vandetanib (ZACTIMA™) in patients with advanced non-small cell lung cancer (NSCLC) presented at American Society of Clinical Oncology  
• • May 20, 2009
  • AstraZeneca and Banner Alzheimer’s Institute expand Alzheimer’s disease collaboration  
• • May 15, 2009
  • Strength and diversity of AstraZeneca oncology portfolio highlighted at ASCO  
• • Apr 17, 2009
  • New national online survey says bipolar depressive symptoms have impact on day-to-day tasks as well as social activities  
• • Apr 15, 2009
  • National survey reveals gap in “uncontrolled asthma” knowledge - putting asthma patients at risk for serious health consequences  
• • Feb 23, 2009
  • AstraZeneca’s partner, MAP Pharmaceuticals, announces Phase 3 study of Unit Dose Budesonide in children with asthma did not meet primary endpoints  
• • Feb 9, 2009
  • AstraZeneca licenses novel antidepressant compounds discovered by Mayo Clinic and Virginia Tech collaboration  
• • Dec 8, 2008
  • AstraZeneca and Targacept announce top-line results from Phase IIb study of AZD3480 in cognitive dysfunction in schizophrenia  

• Pages
• Previous
• 1
• 2

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed